Journal Home
Search for

Volume 58, Issue 12, Pages 947-954 (15 December 2005)


View previous. 9 of 20 View next.

Brain Serotonin1A Receptor Binding in Major Depression Is Related to Psychic and Somatic Anxiety

Gregory M. SullivanaCorresponding Author Informationemail address, Maria A. Oquendoa, Norman Simpsona, Ronald L. Van Heertumb, J. John Mannab, Ramin V. Parseya

Received 18 November 2004; received in revised form 29 April 2005; accepted 4 May 2005. published online 25 July 2005.

Background

The anxious phenotype of the 5-HT1A receptor knockout mouse and the anxiolytic properties of 5-HT1A agonists suggest that the 5-HT1A receptor modulates anxiety. We investigated the relationship of anxiety expressed in major depressive disorder (MDD) to regional 5-HT1A binding.

Methods

Positron emission tomography with [carbonyl-11C]WAY-100635 was used to estimate regional 5-HT1A binding potential (BP) in 28 medication-free MDD subjects. Stepwise linear regression assessed the predictive capacity of three anxiety components, derived from a larger MDD sample and termed psychic, somatic, and motoric anxiety, on regional 5-HT1A BP.

Results

Higher psychic (β ≥ .63) and lower somatic (β ≤ –.70) anxiety predicted over 50% of the variance in 5-HT1A BP in multiple cortical regions, but not in amygdala, hippocampus, or autoreceptors of the raphe nuclei. The psychic and somatic anxiety components were not related to depression severity. Comorbid panic disorder was associated with lower cortical and subcortical 5-HT1A BP.

Conclusions

The 5-HT1A receptor in the same brain regions has different relationships to psychic anxiety versus somatic anxiety. Lower 5-HT1A BP in panic disorder may be accounted for by higher somatic and lower psychic anxiety. Further study of the pathobiology of these anxiety components may identify distinct therapeutic targets or mechanisms.

a Division of Neuroscience, Department of Psychiatry, New York, New York

b Department of Radiology, Columbia College of Physicians and Surgeons, New York, New York

Corresponding Author InformationAddress reprint requests to Gregory M. Sullivan, M.D., Division of Neuroscience, Department of Psychiatry, Columbia University, 1051 Riverside Drive, Unit 41, New York, NY 10032.

PII: S0006-3223(05)00582-2

doi:10.1016/j.biopsych.2005.05.006


View previous. 9 of 20 View next.